Phase 3 N=100 The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy
Pain, Postoperative
Primary: Pain Visual Analog Scale (VAS) Score — 4.4; 5.7 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=40 Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer
Chronic Insomnia
Primary: Sleep Efficiency — 79.70; 85.21 percentage of sleep efficiency
N/A N=20 The Effects of Fractional CO2 Laser on Poikiloderma of Civatte
Poikiloderma of Civatte
Primary: Change in Overall Improvement of Poikiloderma of Civatte (POC) From Baseline at 12 Weeks — 11.01; 6.03; 8.51; 5.89 percentage
Phase 2 N=144 An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas
Non-Hodgkin's Disease
Primary: Safety Analysis - Number of Participants With Dose Limiting Toxicities (DLT) in the DLT Evaluation Phase — 0; 0; 0 Participants
N/A N=23 Feasibility Study of the TruSculpt Radiofrequency Device
Tissue Tightening
Primary: Investigator Assessment of Improvement — 0.67 score on a scale
N/A N=120 Remote Delivery of Weight Management for Adults With IDD
Obesity
Primary: Change in Weight (kg) — -2.1; -4.9 kg
N/A N=99 Study of Hyperkyphosis, Exercise and Function-SHEAF
Kyphosis
Primary: Change in Cobb Angle of Kyphosis — -3.3; -0.3 Degrees
N/A N=152 A Telehealth Advance Care Planning Intervention in Those With Mild Cognitive Impairment or Unrecognized Dementia
Advance Care Planning · Telemedicine · Mild Cognitive Impairment
Primary: Number of Patient/Care Partner Agreeing to Participate — 152 Participants
N/A N=19 Engaging Siblings of Adults With Autism in Future Planning
Autistic Disorder
Primary: Quality of Sibling Plan of Action — 6.00; 5.44; 6.43; 6.56 units on a scale
N/A N=500 A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women
Alcohol Drinking · Alcohol Abuse · Alcohol; Harmful Use
Primary: Change in Number of Drinks Per Week From Baseline to the the 2 Month Follow-up — 2.75; 1.99; -.68 alcoholic drinks per week — p=.0001
Phase 3 N=355 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
Diabetic Macular Edema
Primary: Mean Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 8 — 6.60; 6.56 BCVA letter score
Phase 4 N=11 Wearing-Off Period of Pharmacological Dilation and Anisocoria
Anisocoria
Primary: Number of Participants With Constricting Response to Pilocarpine 1% in the Pharmacologically Dilated Eye — 3 Participants
Phase 2 N=11 Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer
Stage III Prostate Cancer · Stage IV Prostate Cancer
Primary: Pre-metastatic Niche Density — 75.6; 62.5 clusters/hpf — p=>0.05
Phase 3 N=201 Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
Surgery
Primary: Measure Participants' Recovery Time Post-Surgery — 3.59; 3.62 hours
N/A N=30 Evaluation of Wear Experience With a Daily Disposable Contact Lens
Contact Lens
Primary: Contact Lens Dry Eye Questionnaire (CLDEQ-8) Survey — 9.5 units on a scale